If a fetus converts from breech to vertex presentation at 35 weeks gestation, is a hip ultrasound still required to screen for developmental dysplasia of the hip?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hip Ultrasound After Late Breech-to-Vertex Conversion

A fetus that converts from breech to vertex at 35 weeks still requires hip ultrasound screening for developmental dysplasia of the hip (DDH), as the prolonged breech positioning through the third trimester maintains the elevated risk for hip dysplasia.

Rationale for Continued Screening

The critical factor is duration of breech positioning, not the presentation at delivery. By 35 weeks gestation, the fetus has spent substantial time in breech position during the period when hip development is most vulnerable to mechanical forces that cause dysplasia. The American Academy of Pediatrics (AAP) specifically identifies breech presentation as a high-risk factor warranting selective ultrasound screening 1, and this risk is based on the mechanical effects of breech positioning on hip development rather than delivery mechanics alone.

Timing of Screening

  • Perform hip ultrasound at 4-6 weeks of chronological age (not corrected age if born preterm after 35 weeks) 1
  • Avoid ultrasound during the newborn period, as the high sensitivity for detecting minor acetabular immaturity and physiologic hip laxity leads to false-positives and potential overtreatment 1
  • The 4-6 week window allows time for normalization of neonatal physiologic immaturity while still enabling early intervention if true dysplasia exists 1

Key Clinical Considerations

Physical examination findings take precedence: If the hip examination shows instability (positive Barlow or Ortolani maneuvers), immediate orthopedic referral is warranted before 4 weeks of age per AAOS guidelines 2. The ultrasound timing recommendation applies specifically to infants with stable hips on examination but risk factors present 1.

The breech risk persists regardless of conversion timing: Studies show that breech presentation at any point carries DDH risk in term infants 3. A fetus in breech position until 35 weeks has experienced the mechanical forces that predispose to dysplasia throughout most of the third trimester.

Important Caveats

  • If this infant is born preterm before 35 weeks gestation, the screening paradigm changes significantly. Recent evidence shows breech presentation is NOT associated with DDH in infants born before 35 weeks 4, 5, with one study showing 0% DDH incidence in breech infants born <29 weeks 5
  • However, if the pregnancy continues to term or near-term (≥35 weeks), standard breech screening protocols apply
  • Female sex compounds the risk, as the AAP specifically recommends selective ultrasound for girls with breech presentation at birth as the highest risk group 1

Practical Algorithm

  1. At birth: Perform careful hip examination (Barlow and Ortolani maneuvers)
  2. If unstable hip: Immediate pediatric orthopedic referral
  3. If stable hip with breech history: Schedule hip ultrasound at 4-6 weeks of age
  4. Do not obtain newborn ultrasound due to high false-positive rate
  5. If ultrasound shows dysplasia: Initiate treatment per orthopedic guidance; limited evidence supports Pavlik harness as first-line treatment 2

The conversion to vertex at 35 weeks does not eliminate the accumulated risk from prolonged breech positioning, making screening ultrasound still medically indicated.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.